Congratulations to Prof. Ben-Neriah and his team on their newest and exciting findings published in Nature!
In the article, Prof. Ben-Neriah and his team show that mutant p53 has an oncogenic effect in the distal gut but a tumor-suppressive effect in the proximal gut, and these opposing properties are determined by the gut microbiome.
Congratulations to Prof. Ruth Galili, Orit Berhani, and Amijai Saragovi for receiving the prestigious Kaye Innovation Awards!
Remarkably, three out of the five recipients are members of the Lautenberg Center, and we take pride in their achievements. The Kaye Innovation Awards are given to inventors from the Hebrew University who are solving real-world problems by translating scientific excellence into successful commercial ventures.
Download the Kaye Brochure 2020
Congratulations to Dr. Yotam Drier on receiving a research grant from the Israel Science Foundation (ISF).
The grant will provide support for the next five years for multiple efforts in the Drier lab to systematically uncover how epigenetic alterations drive liver cancers. In addition the ISF will help establish the new Drier lab by supporting advanced experimental equipment and high-end computational infrastructure in a separate new faculty equipment grant.
Israel Science Foundation 2020 Winners of KillCorona - Curbing Coronavirus have been announced.
The group led by Prof. Michal Baniyash, together with Dr. Alex Rouvinski, Prof. Michael Steinitz and Prof. Ofer Mandelbiom will receive the Israel Science Foundation grant for the development of therapeutic human monoclonal antibodies against SARS-CoV-2.
Prof. Rami Aqeilan has been elected to serve as the next head of the Institute for Medical Research Israel-Canada (IMRIC) Chairperson.
The Aqeilan’s laboratory won the prestigious proof-of-concept ERC (PoC-ERC) grant to develop a cure for WOREE syndrome.
Studying SARS-CoV-2 at the Lautenberg Center
Dr. Oren Parnas and Dr. Yotam Drier collaborate and use their labs’ resources and advanced techniques to study the coronavirus tissue distribution during infection period, and to study the regulation of the human receptor that allows viral entry to cells. These may lead to novel detection and treatment approaches against SARS-CoV-2.
Prof. Dana Wolf and Dr. Yotam Drier have led efforts to test and implement simple and sensitive pooling approaches to increase the efficiency of clinical testing for SAR-CoV-2.
Thanks to these efforts the throughput of tests of asymptomatic populations at the Hadassah Medical Center increased more than 7-fold, allowing efficient screening of healthcare personnel and nursing homes. This approach can be easily implemented in other clinical labs and drew worldwide attention.
Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
Dr. Saleh Khawaled and Prof. Aqeilan show the role of the tumor suppressor WWOXs and its therapeutic potential in antagonize metastasis.